Money Vesta | News

Dr. Reddy's Laboratories’arm recalling Morphine Sulfate extended release tablet, led to stock decline on the BSE

November 18th, 2024 News
Dr. Reddy's Laboratories’arm recalling Morphine Sulfate extended release tablet, led to stock decline on the BSE

Dr. Reddy's Laboratories’ US-based subsidiary -- Dr Reddy's Laboratories Inc is recalling 2,040 bottles of 15 mg Morphine Sulfate extended-release tablets due to ‘Failed Impurities/Degradation Specification’. It is also recalling another 532 100-count bottles of the medication in 30 mg strength for the same reason.

Dr Reddy's initiated the Class II nationwide recall on October 22 this year.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.


Source: Ace Equity Nxt

Related Post

Play Store App Store Instagram Linkedin Whatsapp
Whatsapp Logo

Moneyvesta
Typically replies within an hour

Moneyvesta
×